CEO Message

“INTIN puts your life and health first.”

INTIN is working diligently to solve social health problems with digital healthcare technology. With convenient and reasonably priced devices and solutions for preventing and treating diseases, we strive to help you maintain a healthy life. “INTIN will strive to deliver health information that customers need us and want to customers.

Digital Healthcare Innovation Company, INTIN

INTIN has a “digital healthcare one-stop process” that directly proceeds from research and development of digital healthcare products, manufacturing and production, domestic sales, and exports.

Our company’s medical device development products received high praise for medical device technology through domestic medical device certification, overseas certification, and CES innovation awards.

Research and Development / HW & SW Manufacturing Production / Quality Certification / Customer Service

INTIN puts customers’ health first, develops, manufactures, and produces innovative digital medical devices, and combines IT and platform technologies optimized for the digital environment to provide the best digital healthcare service in the medical device industry.

Quality Certification

INTIN’s medical devices have acquired GMP production facilities and ISO13485 (Medical Device Quality Management System) and comply with the standards for manufacturing and quality control of medical devices.

Domestic Patent / International Patent

INTIN is registered and applied for more than 110 domestic and international patents and design trademarks. In order to protect our intellectual property, we are acquiring domestic and overseas patents and conducting domestic and foreign patent analysis.

History

INTIN was established in 2009, started the establishment of a research institute in 2014, and continues to research and develop digital healthcare.

2022

August

MOU between Labgenomics and INTIN

January

OVIEW Multi CES Innovation Award

2021

December

Patent Management Commendation Award

November

IP R&D Best Minister Award

July

Relocation of Head Quarter Office Building

May

Selected as one of the 1,000 National Representative Innovative Companies

January

OVIEW Sperm Tester, certified as excellent R&D innovative product

2020

December

Investment from Union Investment Partners

OVIEW Sperm Tester Distribution to Seoul Government Clinic

September

Investment from Small and Medium Business Corporation

June

Minister of Trade, Industry and Energy Award

2019

November

Awarded by the Minister of Science and ICT

June

Exporting contract to Russia

April

OVIEW Sperm Tester and Ovulation Tester exported to Japan

January

Paraffin bath launched

2018

December

Delivery of OVIEW Ovulation tester to 8 public health centers in Daegu

October

Launched OVIEW Sperm Tester

August

Company name changed to INTIN

July

Intellectual property management certification

May

National Intellectual property commission chairperson award

February

OVIEW Ovulation Tester approved by US FDA

January

Selected for Global IP Star

2017

December

Delivery of OVIEW Ovulation Testers to 22 public health centers in Seoul

November

OVIEW Ovulation Test Awarded as Korean Intellectual Property Office Award

July

Approval of the Business Vitality Promotion Act by the Ministry of Trade, Industry and Energy

January

OVIEW Ovulation Tester launched

2016

December

Registered as a venture business

November

Philips Healthcare Challenge Runner-up

July

OVIEW awarded as Global Brand

2014

October

Established an affiliated research institute